$Histogeni_老虎社区_美港股上老虎

2021-03-08

$Histogenics Corporation(OCGN)$A great win for Atmanirbhar Bharat! India’s indigenously developed #COVAXIN shows 81% interim efficacy in Phase 3 trial. We are now one step closer to winning the fight against **. from ICMR

巴拉特生物取得了巨大的胜利！印度本土开发的#COVAXIN在3期试验中显示出81％的中期疗效。现在，我们距离赢得对抗**的战斗又迈出了一步。

免责声明：上述内容仅代表发帖人个人观点，不构成本平台的任何投资建议。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"detailType":1,"isChannel":false,"data":{"magic":2,"id":320530291,"tweetId":"320530291","gmtCreate":1615135644913,"gmtModify":1703484931251,"author":{"id":3463341005279592,"idStr":"3463341005279592","authorId":3463341005279592,"authorIdStr":"3463341005279592","name":"徐州垃圾股战斗机","avatar":"https://static.tigerbbs.com/6e4f5025873234ad12c3bc45049e174a","vip":1,"userType":1,"introduction":"","boolIsFan":false,"boolIsHead":false,"crmLevel":1,"crmLevelSwitch":0,"individualDisplayBadges":[],"fanSize":97,"starInvestorFlag":false},"themes":[],"images":[{"img":"https://static.tigerbbs.com/715c753aa03cff29ec14ff919e1dda06","width":"800","height":"2000"}],"coverImages":[{"img":"https://static.tigerbbs.com/715c753aa03cff29ec14ff919e1dda06","width":"800","height":"2000"}],"extraTitle":"","html":"<html><head></head><body><a href=\"https://laohu8.com/S/OCGN\">$Histogenics Corporation(OCGN)$</a>A great win for Atmanirbhar Bharat! India’s indigenously developed #COVAXIN shows 81% interim efficacy in Phase 3 trial. We are now one step closer to winning the fight against **. from ICMR巴拉特生物取得了巨大的胜利！ 印度本土开发的#COVAXIN在3期试验中显示出81％的中期疗效。 现在，我们距离赢得对抗**的战斗又迈出了一步。<img src=\"https://static.tigerbbs.com/715c753aa03cff29ec14ff919e1dda06\" tg-width=\"800\" tg-height=\"2000\"></body></html>","htmlText":"<html><head></head><body><a href=\"https://laohu8.com/S/OCGN\">$Histogenics Corporation(OCGN)$</a>A great win for Atmanirbhar Bharat! India’s indigenously developed #COVAXIN shows 81% interim efficacy in Phase 3 trial. We are now one step closer to winning the fight against **. from ICMR巴拉特生物取得了巨大的胜利！ 印度本土开发的#COVAXIN在3期试验中显示出81％的中期疗效。 现在，我们距离赢得对抗**的战斗又迈出了一步。<img src=\"https://static.tigerbbs.com/715c753aa03cff29ec14ff919e1dda06\" tg-width=\"800\" tg-height=\"2000\"></body></html>","text":"$Histogenics Corporation(OCGN)$A great win for Atmanirbhar Bharat! India’s indigenously developed #COVAXIN shows 81% interim efficacy in Phase 3 trial. We are now one step closer to winning the fight against **. from ICMR 巴拉特生物取得了巨大的胜利！ 印度本土开发的#COVAXIN在3期试验中显示出81％的中期疗效。 现在，我们距离赢得对抗**的战斗又迈出了一步。","highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":1,"repostSize":0,"favoriteSize":0,"link":"https://laohu8.com/post/320530291","repostId":0,"isVote":1,"tweetType":1,"viewCount":2507,"commentLimit":10,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"symbols":["OCGN"],"verified":2,"subType":0,"readableState":1,"langContent":"CN","currentLanguage":"CN","warmUpFlag":false,"orderFlag":false,"shareable":true,"causeOfNotShareable":"","featuresForAnalytics":[],"commentAndTweetFlag":false,"andRepostAutoSelectedFlag":false,"upFlag":false,"length":311,"xxTargetLangEnum":"ZH_CN"},"commentList":[],"isCommentEnd":true,"isTiger":false,"isWeiXinMini":false,"url":"/m/post/320530291"}